Click HERE to participate in WhiMSICAL!
Daniela Calamai, from Pisa, Italy, shares WM with her mother who has lived with it for almost 30 years.
There is exciting news for WMers in England, and hopeful news for those in Australia, as health agencies have recently approved ibrutinib for WM (England) and CLL/SLL (Australia).
The initial findings from WhiMSICAL, the first-of-its-kind patient- and researcher-led WM database will be presented at upcoming medical conferences. But, we need your help!
This website is supported in part by unrestricted educational grants from Amgen Inc., Pharmacyclics LLC , and
Janssen Biotech, Inc.